EDIT

EDITAS MEDICINE INC

EDIT·28106W103·US·Common Stock·Healthcare - Biotechnology-13D/G

EDIT (EDITAS MEDICINE INC) is held by 102 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($22.9M), VANGUARD CAPITAL MANAGEMENT LLC ($10.4M), RENAISSANCE TECHNOLOGIES LLC ($9.8M). Net institutional sentiment: Mixed.

102
Holders
Avg rating(30 Elite)
$110.4M
Total Value
54% (111)
Fund Consensus
54 buying - 46 selling
EDITSmart Money Verdict
View all
Held by 102 funds
30 elite
Who's Trading
InsiderONO'Neill Gilmore NeilSell $42KJun 3, 2026
InsiderBLBurkly LindaSell $2KJun 3, 2026
ActivistTCTCG Crossover GP III, LLC9.9%Jun 3, 2026
InsiderPAParison AmySell $1KJun 3, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.5.8%Jun 3, 2026
ActivistCOCommodore Capital LP9.9%Jun 2, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderONO'Neill Gilmore NeilSell $11KMar 3, 2026
InsiderBLBurkly LindaSell $2KMar 3, 2026
InsiderPAParison AmySell $957.48Mar 3, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
9.3M(-0.9%)$22.9M0.0%+99.77%
0
New
4.2M$10.4M0.0%+59.80%
38
Increased
4M(+30.7%)$9.8M0.0%+63.24%
35
New
3.1M$7.8M0.0%+59.80%
38
Increased
2.3M(+1.2%)$5.7M0.0%-79.80%
27
Increased
2.1M(+5.1%)$5.1M0.0%-60.60%
28
Increased
2M(+0.0%)$4.9M0.0%+16.40%
27
Increased
1.9M(+75.2%)$4.8M0.0%+46.59%
41
Increased
1.9M(+148.7%)$4.3M0.0%+85.00%
43
Decreased
1.5M(-5.1%)$3.8M0.0%-44.57%
0
Increased
1.4M(+112.8%)$3.4M0.0%+57.38%
43
Increased
1.3M(+9.2%)$3.2M0.0%+68.60%
29
Increased
861,326(+8.4%)$2.1M0.0%-75.97%
28
Increased
742,443(+12.1%)$1.8M0.0%-81.13%
29
New
730,054$1.8M0.0%+59.80%
36
Decreased
662,389(-19.3%)$1.6M0.0%+41.87%
0
New
614,036$1.5M0.0%+59.80%
35
Decreased
582,309(-29.6%)$1.4M0.0%-2.17%
0
Decreased
558,577(-36.7%)$1.4M0.0%+93.91%
0
Decreased
411,192(-39.4%)$1M0.0%+18.42%
0

Showing 1-20 of 111

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used